The pLKO.1-GFP-LXRα shRNA Plasmids were purchased from Santa Cruz Biotechnology, Inc. (cat. no. sc-38829-SH). The transfected shRNA plasmid is a pool of 3 target-specific lentiviral vector plasmids. The three shRNA sequences are: Sequence #1, 5′-CCGGGATCTGGGATGTGCACGAATGCTCGAGCATTCGTGCACATCCCAGATCTTTTTTG-3′; sequence #2, 5′-CCGGAGTTCTCCAGGGCCATGAATGCTCGAGCATTCATGGCCCTGGAGAACTTTTTTTG-3′; and sequence #3, 5′-CCGGGCAACTCAATGATGCCGAGTTCTCGAGAACTCGGCATCATTGAGTTGCTTTTT-3′. The control pLKO.1-GFP-shRNA plasmid encodes a scrambled shRNA sequence that will not lead to the specific degradation of any cellular message. shRNA transfection was performed using the Lipofectamine® 3000 (cat. no. L3000008; Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Briefly, transfection was performed in a six-well tissue culture plate, at a density of 6×105 cells with 50–70% confluency in antibiotic-free normal growth medium supplemented with FBS. Plasmid (1 µg) was transfected into 4×105 cells/well. Subsequently, 72 h later, the cells were collected for downstream assays. The transfection efficiency was determined by RT-qPCR.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.